Clinical Trials Browser

Phase 3 × Sunscreening Agents × Clear all

NCT00362986 2016-12-13

Topical Sunscreen in Preventing Skin Rash in Patients Receiving Drugs Such as Erlotinib or Cetuximab for Cancer

Phase 3 Completed

Other solid neoplasm

Dermatologic Complications